Edition:
United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

561.90INR
23 Feb 2018
Change (% chg)

-- (--)
Prev Close
Rs561.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
80,684
52-wk High
Rs648.00
52-wk Low
Rs469.85

Select another date:

Wed, Jan 31 2018

BRIEF-India's Alembic Pharmaceuticals Dec Qtr Consol PAT Rises

* DEC QUARTER CONSOL NET PAT 1.31 BILLION RUPEES VERSUS 843.9 MILLION RUPEES YEAR AGO

BRIEF-Alembic Pharmaceuticals Says U.S. FDA Grants Orphan-Drug Designation To Rhizen Pharmaceuticals

* U.S. FDA GRANTS ORPHAN-DRUG DESIGNATION FOR TENALISIB TO RHIZEN PHARMACEUTICALS S.A. (RHIZEN) Source text - http://bit.ly/2C7DIYd Further company coverage:

BRIEF-Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder

* DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER Source text: http://bit.ly/2BVyJWK Further company coverage:

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

BRIEF-Alembic Pharma buys generic drug developer Orit Laboratories

* Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​ Source text: http://bit.ly/2z3AKCI Further company coverage:

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage:

Select another date: